TSHA earnings: a negative outcome, -6.2%

On March 28, 2023, Taysha Gene Therapies, Inc. reached its earnings. The result was a negative outcome, and the stock moved -6.2% in the window around the event. It had already run -28.7% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.